<Know the future, create the future>
Intel provides innovative driving force for business development change
Today, Intel "know the future, create the future - business change trend conference" was held in Beijing. Liang Yali, General Manager of Intel Industry Solutions Group China, delivered a keynote speech at the conference, expounding Intel's data strategy in the era of data explosion, and deeply analyzing Intel's full-stack strength from cloud to end, with innovative technology and leading edge. The solution is to promote Chinese companies in the retail, medical and financial industries to turn data into development momentum, actively drive business transformation, and help companies to take a strategic advantage in future competition. Analysts from the retail industry, the healthcare industry, and the Economist Intelligence Unit have also come together to share the importance of the adoption of new technologies for the future success of the business and how to address the data challenges of the digital economy.
At the conference, Intel also unveiled the latest survey report entitled "Bridging the Gap of the New Technology Paradigm" in conjunction with The Economist Intelligence Unit (EIU). The Economist Intelligence Unit (EIU) surveyed 350 Chinese companies, including their attitudes, plans, and strategies for adopting technology solutions to improve products or services. The main targets of the survey are companies in the financial, retail and medical industries. Some of the key findings of this survey include:
Important discovery
- >> More than two-thirds of companies say they have a clear vision and strategy for using new technologies in their products and services.
- >> Many of the absorption of new technologies is driven by cooperation with technology companies.
- >> Flexible financial technology companies have spurred traditional financial companies, and they realized the need to increase the adoption of technology.
- >> In the face of competition, some retail companies that believe in innovation will use their expertise to provide integrated solutions for online and offline shopping and supply chain.
- >> The main technical goal of the medical industry is to improve the medical experience.
Wang Dan, an economist think tank analyst, further shared that over the years, Chinese companies have been able to use technology to improve internal efficiency by accelerating internal processes, reducing input per unit of output, and helping companies better conduct business. Now a new paradigm is emerging: bringing cutting-edge technologies such as cloud computing, big data and remote connectivity directly into the products and services themselves. This is changing the nature of the company's output, helping them enter new markets and delighting customers, and in some cases laying the groundwork for a new business model.
The current development of emerging technologies represented by cloud computing, big data, artificial intelligence, etc. is in the ascendant, and its development in China is particularly rapid. Chinese companies are actively adopting new technologies to win the future. Intel has always been committed to building the industry chain, based on its core strengths and expanding technology layout, through analysis, calculation and full-stack strength of mobile data, and cooperation with the majority of partners to help users in the retail, medical, financial and other industries Dig the value of data and take the lead in the future of smart internet in a more flexible and efficient way. For example, in responsive retail, Intel has helped deploy McDonald's smart restaurants to integrate online and offline; cooperate with Wanda to help them. Feifan Smart Business Platform (ffan.com) provides smart services to more consumers. In the medical field on the Intel artificial intelligence platform, Deshang Yunxing and the First Affiliated Hospital of Zhejiang University have improved and optimized the algorithm for the thyroid nodules ultrasound image data, and used the large samples obtained to train the computer with accurate diagnosis. The rate has increased to 85%.
Liang Yali, General Manager, Intel Industry Solutions Group China
Liang Yali, general manager of Intel Industry Solutions Group China, said: "The insights of the Economist Intelligence Unit profoundly reveal how companies can use cloud computing, big data, artificial intelligence and other new technologies to drive the future development and transformation of enterprises. This is in line with Intel's data strategy. It is better to predict the future than to create the future. Intel has always been committed to leveraging its technological and ecological advantages, actively writing innovations with partners in the medical and retail industries, and through the accumulation of leading technologies and innovation capabilities. The industry provides a driving force for business transformation and innovation, and actively helps Chinese companies to win the future."
PRODUCT | SPECIFICATION | NORMAL PACKING |
Amikacin | Injection 0.5g/2Ml | 10vials/Box |
Amoxycillin |
Powder Inj 0.25g 0.5g. Capsule 0.25g,0.5g For Syrup 250mg/5Ml |
50vials/Box 10`sx10/Box 60ml/Vial |
Amoxycillin + Clavulanate K |
Powder In. 600mg 1.2g (5+1) Tablet 375mg (2+1) Dry Syrup 375mg (2+1) 60ml |
10vials/Box 6tabls/Box 1`s/Box |
Ampicillin |
Powder Inj 0.25g 0.5g 1.0g For Syrup 250mg/5Ml |
50vials/Box 60ml/Vial |
Azithromycin | Tablet 0.25g,0.5g | 10`s/Blister |
Aztreonam | For Injection 0.5g | 10Vial/Box |
Cefazolin Sodium | Powder Injection 0.5g | 50vials/Box |
Cefotaxime Sodium | Powder Inj. 1g | 10vials/Box |
Cefoperazone Sodium | Powder inj. 0.5g 1g | 1vial/Box |
Ceftazidine | Powder Inj. 1g | 1vial/Box |
Ceftriaxone Sodium | Powder Inj 1g | 1vial/Box |
Cefuroxime Sodium | Powder Inj. 750mg | 10vials/Box |
Chloramphenicol |
Capsule 250mg Succinate Injection 1g |
1000's/Tin 50vials/Box |
Ciprofloxacin Hcl |
Tablet 0.5g 0.25g Infusion 100ml |
10'sx10blister/Box Bottle |
Doxycycline |
Capsule 100mg Tablet 250mg |
10'sx100blister/Box 10's/Blister |
Gentamicin |
Injection 80mg/2ml Eye & Ear Drop 0.4% 10ml |
100's/Box 10pieces/Box |
Lincomycin |
Injection 600mg/2ml Capsule 500mg |
5amps/Box 12'sx2blister/Box |
Meropenem | Powder inj. 500mg; 1G | 1`s/Box |
Crystal Penicillin Sodium | Powder Inj.1mega 5mega | 50vials/Box |
Procainpenicillin Fortified | Powder Inj. 0.4mega; 4mega | 50vials/Box |
Streptomycin | Powder Inj 1.0g; 5.0g | 50vials/Box |
Tetracycline |
Capsule 250mg Eye Onitment 0.1% 4g |
1000's/Tin 1tube/Box |
Oflox Infusion,Amoxicillin Sodium,Lincomycin Capsule,Co Amoxiclav Suspension
NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com